James T. Treace, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 100,000 shares at $15.77 ($1.6M) on 2022-05-26, disclosed to the SEC on 2022-05-27.
Open-market sale of $1.6M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.35 | 30,313 | $465K | 30.0% |
| 2 | $15.35 | 30,313 | $465K | 30.0% |
| 3 | $15.77 | 19,687 | $310K | 20.0% |
| 4 | $15.77 | 19,687 | $310K | 20.0% |
| Total | $15.52 avg | 100,000 | $1.6M | 100% |
| Filing → |
| TMCI | BUY | 2024-05-30 | $130K | — | Filing → |
| TMCI | BUY | 2024-05-29 | $254K | — | Filing → |
| TMCI | BUY | 2024-05-13 | $1.0M | — | Filing → |